Sept. 1, 2023, 2:57 p.m. |

Latest stories for ZDNET in Artificial-Intelligence www.zdnet.com

Recursion Pharmaceuticals uses machine learning to develop drugs with Bayer and Genentech. CEO Chris Gibson thinks proceeding with that work outweighs any risks a moratorium might prevent.

ai research ceo chris drugs genentech machine machine learning pharma pharmaceuticals recursion recursion pharmaceuticals research risks work

Data Architect

@ University of Texas at Austin | Austin, TX

Data ETL Engineer

@ University of Texas at Austin | Austin, TX

Lead GNSS Data Scientist

@ Lurra Systems | Melbourne

Senior Machine Learning Engineer (MLOps)

@ Promaton | Remote, Europe

Data Scientist

@ Publicis Groupe | New York City, United States

Bigdata Cloud Developer - Spark - Assistant Manager

@ State Street | Hyderabad, India